Clinical Trials Browser

Recruiting × Neurofibromatoses × 1 year × Clear all

NCT00598351 2026-04-14

Natural History Study of Patients With Neurofibromatosis Type 2

Ependymoma, Meningioma, Neurilemmoma, Neuroma, Acoustic, Spinal Cord Neoplasms, Neurofibromatoses

NCT07088991 2026-03-31

NEREUS

Neurofibromatoses

NCT07233408 2026-02-27

Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy

Phase NA Recruiting

Neurofibromatosis 1, Neurofibromatoses

NCT07102394 2026-02-17

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

Phase 1 Recruiting

Neurofibroma, Neurofibromatosis 1, Neurofibromatoses

NCT06147414 2026-01-15

DANNIgene

CNSClassical hematologyGenitourinary

Hydrocephalus, X-linked, Neurofibromatosis-Noonan syndrome, Anemia, Sickle Cell, Hemophilia B, Cystic Fibrosis, Fragile X Syndrome, Hemophilia A, Huntington Disease, Myotonic Dystrophy, Polycystic Kidney, Autosomal Recessive, Neurofibromatoses, Muscular Dystrophy, Duchenne

NCT06961565 2025-12-04

PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas

Phase 1 Recruiting

Neurofibromatosis 1, Neurofibromatoses, Neurofibroma, Plexiform

NCT07237100 2025-11-19

Mirdametinib in Patients With Advanced NF1-mutant Melanoma

Phase 2 Recruiting

CNSDermatologic

Melanoma, Neurofibromatoses

NCT06262113 2025-10-03

A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1

Phase NA Recruiting

Neurofibromatosis 1, Neurofibromatoses

NCT05489783 2025-06-29

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

Glioma, Neurofibromatoses